Federal Circuit Quashes $287 Million Enhanced Damages Award Finding Objectively Reasonable Defenses Raised During Litigation

Aug 11, 2015

Reading Time : 1 min

In Carnegie Mellon Univ. v. Marvel Tech. Grp., Ltd., a jury awarded over a billion dollars in damages after finding Marvel had infringed Carnegie Mellon’s patents. The district court added 23 percent in enhanced damages after finding willful infringement on the grounds that Marvel’s trial defenses were not objectively reasonable and that Marvel knew of should have known its actions would infringe the patents. On appeal, the Federal Circuit held Marvel had presented defenses during the litigation that were objectively reasonable.

First, the court rejected the district court’s premise that a reasonable defense had to be known to Marvel during the time prior to the litigation. Quoting In re Seagate, the court reiterated that “‘[t]he state of mind of the accused infringer is not relevant to th[e] objective inquiry’ into the risk of liability to the defendant necessary for a finding of recklessness.” Citing further precedent, the court held there is no temporal aspect to the objective reasonableness of a defense, i.e. Marvel need not have “had the defense in mind before the litigation.”

Second, the court rejected the district court’s distinction between those defenses presented at trial and those raised an earlier stage, such as during summary judgment proceedings. The court held objectively reasonable defenses can include “claim­construction arguments [and] other defense that [do] not make the cut for consuming precious time and attention of the jury. Indeed, the court noted the record of defenses as a whole must be examined, and that the “record is not limited to evidence presented to the jury.” Thus, Marvel did not have to present a defense to the jury for that defense to be found objectively reasonable.

Carnegie Mellon Univ. v. Marvel Tech. Grp., Ltd., No. 2014­1492 (Fed. Cir. Aug. 4, 2015) [Taranto (opinion), Wallach, Chen].

Share This Insight

Categories

Previous Entries

IP Newsflash

December 9, 2025

The Federal Circuit recently denied a petition for a writ of mandamus that challenged the PTO Director’s reliance on “settled expectations” to discretionarily deny two inter partes review (IPR) petitions. In so doing, the court explained that, while it was not deciding whether the Director’s use of “settled expectations” was correct, the petitioner’s arguments about what factors the Director may consider when deciding whether to institute an IPR or post-grant review (PGR) are not generally reviewable and did not provide sufficient basis for mandamus review here.

...

Read More

IP Newsflash

December 5, 2025

District courts are split on whether a complaint can provide the required knowledge for post-suit indirect and willful infringement in that same lawsuit. Chief Judge Connolly in the District of Delaware recently confirmed that, consistent with his prior opinions, the complaint cannot serve as the basis for knowledge for either a claim of post-suit indirect infringement or a demand for willfulness-based enhanced damages in that lawsuit.

...

Read More

IP Newsflash

December 3, 2025

The Federal Circuit recently held that a patentee acted as its own lexicographer to define a claim term even though it did not explicitly define the term. Rather, because the patentee consistently and clearly used two terms interchangeably to describe the same structural feature and did so in all of the embodiments in which the feature appeared, the patentee impliedly gave the term its own, unique definition.

...

Read More

IP Newsflash

December 2, 2025

The Federal Circuit recently held an asserted patent was not entitled to its priority date because the priority application lacked written description support for the asserted claims. In so doing, the court explained that broad disclosures that do not provide reasonably specific support for narrower claims do not meet the written description requirement. The court also considered whether the inventor’s testimony showed they possessed the full scope of the claimed genus at the priority date or whether it was more likely the inventors first became aware of the claimed embodiments from public disclosures of the accused product.

...

Read More

© 2025 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.